Sartorius Muscle Myopathy

Sartorius muscle myopathy is a pathological condition affecting the sartorius muscle, a fusiform muscle located in the medial compartment of the thigh. It originates from the iliac crest and lumbar fascia and inserts on the medial aspect of the tibia via the pes anserinus. The muscle is composed of two heads: the superficial (cranial) head and the deep (caudal) head, which are innervated by branches of the femoral nerve. Sartorius muscle myopathy encompasses a spectrum of disorders including traumatic injury (strain, partial or complete tear), ischemic myopathy, inflammatory myositis, and rarely, neoplastic infiltration. In veterinary surgery, it is most commonly encountered as a result of acute trauma or overexertion, leading to muscle fiber disruption, hemorrhage, and subsequent fibrosis. The condition can cause significant lameness, pain, and functional impairment of the stifle and hip joints. Surgical intervention may be required for severe tears or chronic fibrotic contracture, which can restrict joint motion and lead to secondary osteoarthritis. The disease is classified based on the severity of muscle damage (mild strain, partial tear, complete rupture) and chronicity (acute vs. chronic). Accurate diagnosis and timely management are crucial to prevent long-term morbidity.

The etiology of sartorius muscle myopathy is multifactorial. Primary causes include traumatic injuries such as direct blunt trauma, penetrating wounds, or excessive stretching during vigorous activity, particularly in athletic or working dogs. Acute muscle strains occur when the muscle is forcibly contracted while being stretched beyond its physiological limits, often during sudden acceleration, jumping, or turning. Ischemic myopathy can result from vascular compromise due to thromboembolism, external compression, or iatrogenic injury during surgery. Inflammatory myopathies, such as immune-mediated myositis, can also affect the sartorius muscle, though they are less common. Infectious etiologies, including bacterial (e.g., Clostridium spp.), protozoal (e.g., Toxoplasma gondii, Neospora caninum), or parasitic (e.g., Trichinella spiralis) infections, may lead to myositis. Neoplastic conditions, such as rhabdomyosarcoma or metastatic infiltration, are rare but possible. Additionally, congenital or developmental abnormalities, such as muscular dystrophy, can predispose to muscle weakness and injury. Iatrogenic causes include surgical trauma during approaches to the hip or stifle, or improper injection techniques. The anatomical location of the sartorius muscle, spanning both the hip and stifle joints, makes it susceptible to strain during combined extension and abduction movements.

Sartorius muscle myopathy is most commonly diagnosed in dogs, particularly in athletic breeds such as Greyhounds, Border Collies, and German Shepherds, which are predisposed to muscle injuries due to high-intensity activities. It is less frequently reported in cats, but can occur in outdoor cats with a history of trauma. There is no distinct age or sex predilection, but young, active animals are at higher risk due to their exuberant activity levels. Working dogs, such as police and military dogs, and agility competitors have an increased incidence of muscle strains. The condition is often underdiagnosed, as mild strains may resolve with conservative management. In a retrospective study of canine muscle injuries, the sartorius muscle accounted for approximately 5% of all muscle strains. Breed-specific anatomical variations, such as a relatively longer sartorius muscle in deep-chested breeds, may increase susceptibility. Additionally, obesity and poor physical conditioning are significant risk factors, as they place excessive stress on the musculotendinous unit. The incidence of traumatic sartorius injuries peaks in the summer months when outdoor activities are more common.

The pathophysiology of sartorius muscle myopathy involves a cascade of cellular and tissue events. In acute traumatic injury, excessive tensile forces cause disruption of myofibrils, sarcolemma, and the extracellular matrix. This leads to hemorrhage, edema, and an inflammatory response characterized by infiltration of neutrophils and macrophages. The release of pro-inflammatory cytokines (e.g., IL-1, IL-6, TNF-α) and growth factors (e.g., TGF-β) promotes the recruitment of fibroblasts and the deposition of collagen, resulting in fibrosis. If the injury is severe, there may be complete rupture of the muscle belly or avulsion from its origin or insertion. Chronic injury or repetitive microtrauma can lead to myositis ossificans, a condition where heterotopic bone forms within the muscle. Ischemic myopathy results from inadequate blood supply, leading to muscle fiber necrosis and subsequent replacement by fibrous tissue. In inflammatory myopathies, immune-mediated mechanisms target muscle antigens, causing lymphocytic infiltration and muscle fiber degeneration. Neoplastic infiltration disrupts normal muscle architecture and function. The sartorius muscle plays a crucial role in hip flexion, abduction, and stifle extension; therefore, any pathology can significantly impair gait and joint stability. Secondary effects include joint contracture, particularly if the muscle becomes fibrotic and shortened, leading to a characteristic 'bunny-hopping' gait.

Intrinsic predisposing factors include conformational abnormalities such as a straight stifle or shallow acetabulum, which alter the biomechanical forces on the sartorius muscle. Genetic predisposition to muscle weakness or myopathy, as seen in certain breeds, can increase susceptibility. Age-related changes, such as decreased muscle elasticity and regenerative capacity, make older animals more prone to injury. Obesity and poor body condition score increase the load on the muscle and reduce flexibility. Metabolic disorders, such as hypothyroidism or hyperadrenocorticism, can cause muscle weakness and atrophy. Extrinsic factors include inadequate warm-up before exercise, sudden changes in activity level, and training on uneven or slippery surfaces. Poor nutrition, particularly deficiencies in protein, vitamin E, and selenium, can impair muscle health. Prior injuries or surgeries in the region may lead to scar tissue formation, altering muscle mechanics and increasing the risk of re-injury. Iatrogenic factors, such as improper surgical technique or injection into the muscle, can directly damage the muscle fibers. Environmental factors, such as cold weather, can reduce muscle blood flow and increase stiffness, predisposing to strains.

Clinical signs of sartorius muscle myopathy vary depending on the severity and chronicity of the injury. In acute cases, animals present with sudden-onset lameness, often non-weight-bearing, and severe pain on palpation of the medial thigh. There may be visible swelling, heat, and bruising in the affected area. The animal may hold the limb in a flexed and abducted position to relieve tension on the muscle. On physical examination, there is pain on passive extension of the hip and stifle, and crepitus may be felt if there is a complete tear. In chronic cases, lameness may be intermittent and less severe, but there is often muscle atrophy and a palpable fibrotic band. Contracture of the sartorius muscle can lead to a restricted range of motion in the hip and stifle, resulting in a shortened stride and a 'bunny-hopping' gait. In severe cases, there may be a visible deformity of the medial thigh. Systemic signs such as fever and lethargy may be present if there is significant inflammation or infection. Neurological deficits are uncommon but may occur if the femoral nerve is compressed by hematoma or fibrosis.

Differential diagnoses for sartorius muscle myopathy include: 1) Iliopsoas muscle strain: presents with similar lameness and pain on hip extension, but pain is localized to the iliopsoas muscle, and there is often a 'pointing' sign on palpation. 2) Hip dysplasia: chronic, bilateral lameness with pain on hip extension and crepitus; radiographs show subluxation and degenerative changes. 3) Cranial cruciate ligament rupture: acute lameness with stifle effusion, positive cranial drawer sign, and radiographic evidence of joint effusion and osteoarthritis. 4) Patellar luxation: intermittent lameness with palpable patellar luxation and stifle deformity. 5) Fracture of the femur or pelvis: severe lameness with crepitus and radiographic evidence of fracture. 6) Neoplastic conditions such as osteosarcoma or soft tissue sarcoma: progressive lameness, palpable mass, and radiographic/CT findings of bone lysis or soft tissue mass. 7) Myositis (e.g., masticatory myositis or polymyositis): generalized muscle pain, weakness, and elevated muscle enzymes. 8) Spinal cord disease (e.g., intervertebral disc disease): neurological deficits, proprioceptive deficits, and spinal hyperesthesia. 9) Septic arthritis: acute lameness, joint effusion, fever, and positive synovial fluid culture. 10) Avulsion of the origin of the sartorius muscle: similar clinical signs, but imaging may show avulsion fragment at the ilium.

The diagnostic algorithm for sartorius muscle myopathy begins with a thorough history and physical examination, including a complete orthopedic and neurological examination. Palpation of the medial thigh may reveal pain, swelling, or a defect in the muscle belly. The next step is to perform diagnostic imaging. Standard radiographs of the pelvis and stifle are useful to rule out fractures, luxations, and joint disease, but they are not sensitive for muscle injuries. Ultrasonography is the preferred modality for evaluating muscle injuries, as it can identify fiber disruption, hematoma, and fibrosis. It is non-invasive and can be performed in the conscious patient. If ultrasonography is inconclusive or if a more detailed assessment is needed, magnetic resonance imaging (MRI) provides excellent soft tissue contrast and can accurately characterize the extent of muscle injury, including partial or complete tears, edema, and fibrosis. Computed tomography (CT) may be used to evaluate for concurrent bone injuries or to guide surgical planning. In cases where inflammatory or neoplastic disease is suspected, a muscle biopsy may be indicated. Laboratory tests, including complete blood count, serum biochemistry, and muscle enzyme levels (creatine kinase, aspartate aminotransferase), can support the diagnosis. Electromyography (EMG) may be used to assess muscle innervation and detect denervation. The diagnostic algorithm should be systematic to ensure an accurate diagnosis and appropriate treatment plan.

Laboratory findings in sartorius muscle myopathy are non-specific but can support the diagnosis. Serum muscle enzymes, particularly creatine kinase (CK) and aspartate aminotransferase (AST), may be elevated in acute muscle injury, with CK peaking within 24-48 hours and returning to normal within 3-5 days. In chronic or inflammatory myopathies, these enzymes may be persistently elevated. Complete blood count may reveal leukocytosis with a left shift in cases of severe inflammation or infection. Serum biochemistry may show elevated globulins in immune-mediated myositis. In cases of suspected infectious myositis, serology for Toxoplasma, Neospora, or other pathogens may be performed. Synovial fluid analysis is not typically indicated unless there is concurrent joint involvement. Coagulation profile (PT, aPTT, platelet count) is important if surgical intervention is planned, especially if there is a history of bleeding disorders. Inflammatory biomarkers such as C-reactive protein (CRP) and serum amyloid A (SAA) may be elevated in acute inflammation. Urinalysis is generally unremarkable. Muscle biopsy, if performed, may show degenerative changes, inflammatory infiltrates, or fibrosis, and can be submitted for histopathology and culture.

Imaging plays a crucial role in the diagnosis and management of sartorius muscle myopathy. Radiography: Standard radiographs of the pelvis and stifle are often normal in acute muscle injuries, but may show soft tissue swelling or calcification in chronic cases. Radiographs are essential to rule out fractures, luxations, and joint disease. Ultrasonography: This is the primary imaging modality for muscle injuries. It can identify muscle fiber disruption, hematoma, edema, and fibrosis. The sartorius muscle can be visualized in the medial thigh, and dynamic imaging during passive joint movement can assess muscle integrity. Ultrasonographic findings include hypoechoic areas representing hematoma or edema, hyperechoic areas indicating fibrosis, and discontinuity of the muscle fibers in complete tears. MRI: MRI provides the most detailed assessment of muscle injuries, with high soft tissue contrast. T1-weighted images show muscle anatomy, while T2-weighted and STIR sequences are sensitive for edema and inflammation. MRI can accurately differentiate between partial and complete tears, identify the extent of muscle involvement, and detect chronic changes such as fibrosis and atrophy. CT: CT is useful for evaluating concurrent bone injuries and for surgical planning, but it is less sensitive than MRI for soft tissue detail. Arthroscopy: If there is concurrent joint pathology, arthroscopy can be performed to evaluate the intra-articular structures. Angiography/Fluoroscopy: These are rarely used but may be indicated if vascular compromise is suspected.

Cytology and histopathology are important for diagnosing inflammatory or neoplastic causes of sartorius muscle myopathy. Fine-needle aspiration (FNA) of a palpable mass or swollen area may yield cells for cytological evaluation. In inflammatory myopathies, cytology may show a mixed population of inflammatory cells, including lymphocytes, plasma cells, and macrophages. In neoplastic conditions, such as rhabdomyosarcoma, cytology may reveal malignant spindle cells with pleomorphism and mitotic figures. However, FNA is often non-diagnostic for muscle injuries, and a muscle biopsy is preferred. Histopathology of a muscle biopsy can reveal characteristic findings: in acute injury, there is muscle fiber degeneration, necrosis, and hemorrhage; in chronic injury, there is fibrosis and atrophy; in inflammatory myopathy, there is lymphocytic infiltration and muscle fiber necrosis; in neoplastic conditions, there is infiltration by neoplastic cells. Special stains, such as Masson's trichrome for fibrosis and immunohistochemistry for inflammatory cell markers, can aid in diagnosis. Surgical margin evaluation is crucial if a neoplastic process is suspected, as wide excision may be necessary.

Treatment of sartorius muscle myopathy depends on the severity and chronicity of the injury. Conservative management is appropriate for mild strains and partial tears. This includes strict rest, cold therapy (ice packs) for the first 24-48 hours to reduce inflammation, followed by warm compresses to promote healing. Non-steroidal anti-inflammatory drugs (NSAIDs) such as carprofen (2.2 mg/kg PO q12h) or meloxicam (0.1 mg/kg PO q24h) are used to control pain and inflammation. Muscle relaxants such as methocarbamol (15-20 mg/kg PO q8h) may be beneficial. Physical therapy, including passive range of motion exercises and controlled leash walks, should be initiated after the acute phase (3-5 days). For severe tears or complete ruptures, surgical intervention is indicated. Surgical options include primary repair of the muscle using a locking-loop or three-loop pulley suture pattern with absorbable monofilament suture (e.g., polydioxanone, size 0 or 2-0). The muscle ends are apposed and sutured, and the limb is immobilized in a flexion bandage or splint for 2-3 weeks. In chronic cases with fibrotic contracture, a tenotomy or myectomy may be necessary to release the contracture and restore joint motion. Postoperative management includes pain control, antibiotics (e.g., cefazolin 22 mg/kg IV q8h) if there is contamination, and a gradual return to activity. Rehabilitation, including therapeutic ultrasound, laser therapy, and swimming, is crucial for optimal recovery.

The prognosis for sartorius muscle myopathy is generally good with appropriate treatment. Mild strains and partial tears have an excellent prognosis with conservative management, with most animals returning to normal function within 2-4 weeks. Complete tears that are surgically repaired also have a good prognosis, with a return to function expected within 6-8 weeks. However, complications such as re-injury, fibrosis, and contracture can occur, especially if rehabilitation is inadequate. Chronic cases with contracture have a guarded prognosis, as surgical release may not fully restore joint motion, and secondary osteoarthritis may develop. Negative prognostic indicators include delayed treatment, severe muscle loss, and concurrent orthopedic injuries. In cases of inflammatory or neoplastic myopathy, the prognosis depends on the underlying cause and response to treatment. Overall, the success rate for surgical repair of sartorius muscle tears is high, with studies reporting good to excellent outcomes in over 80% of cases.

Follow-up care for sartorius muscle myopathy is essential to monitor healing and prevent complications. For conservative management, re-evaluation should occur at 2 weeks to assess lameness and pain. If surgical repair was performed, sutures are typically removed at 10-14 days. Serial radiographic or ultrasonographic evaluations may be performed at 4, 8, and 12 weeks to assess muscle healing and fibrosis. Restricted activity is recommended for 4-6 weeks, with a gradual increase in exercise. Physical therapy should be continued for at least 6-8 weeks, including passive range of motion exercises, massage, and controlled walking. In cases of contracture, long-term monitoring for joint function is necessary. Owners should be educated on the signs of re-injury, such as sudden lameness or swelling, and advised to seek immediate veterinary care. Long-term follow-up at 6 months and 1 year may be recommended to assess for the development of osteoarthritis or chronic pain.

Clinical pearls: 1) The sartorius muscle is often overlooked as a cause of lameness; always palpate the medial thigh in cases of hip or stifle lameness. 2) Ultrasonography is a valuable, non-invasive tool for diagnosing muscle injuries; it can be performed in the conscious patient. 3) In acute injuries, early cold therapy and rest are crucial to minimize inflammation and fibrosis. 4) When repairing a complete tear, use a locking-loop suture pattern with absorbable monofilament suture to provide strong apposition. 5) Postoperative rehabilitation is as important as surgery; a structured physical therapy program improves outcomes. Pitfalls: 1) Failure to diagnose a complete tear may lead to chronic lameness and contracture. 2) Inadequate rest or premature return to activity can result in re-injury. 3) Overuse of NSAIDs can cause gastrointestinal or renal side effects; use the lowest effective dose for the shortest duration. 4) In chronic cases, simple tenotomy may not be sufficient; a myectomy may be required to achieve full range of motion. 5) Ignoring concurrent orthopedic conditions, such as hip dysplasia, can lead to persistent lameness despite successful muscle repair.

Perioperative pharmacological protocols for sartorius muscle myopathy are based on Plumb's Veterinary Drug Handbook. Preoperative: Administer prophylactic antimicrobials such as cefazolin (22 mg/kg IV) 30 minutes before incision, and repeat every 90 minutes during surgery. For pain management, premedicate with an opioid such as hydromorphone (0.05-0.1 mg/kg IV) or methadone (0.1-0.3 mg/kg IV). Intraoperative: Maintain anesthesia with inhalant anesthetics (isoflurane or sevoflurane) and consider a constant rate infusion (CRI) of fentanyl (5-10 mcg/kg/hr IV) or lidocaine (25-50 mcg/kg/min IV) for additional analgesia. Postoperative: Provide multimodal analgesia with an opioid (e.g., buprenorphine 0.01-0.02 mg/kg IV q8h) and an NSAID (e.g., carprofen 2.2 mg/kg PO q12h for 3-5 days, or meloxicam 0.1 mg/kg PO q24h). If muscle relaxants are needed, methocarbamol (15-20 mg/kg PO q8h) can be used. For inflammatory myopathies, corticosteroids such as prednisone (1-2 mg/kg PO q24h) may be indicated, but should be used with caution. Chondroprotectants such as glucosamine/chondroitin sulfate (e.g., 500-1000 mg PO q24h) may be beneficial for concurrent joint disease. Adjust dosages in patients with renal or hepatic impairment. Monitor for adverse effects, especially gastrointestinal ulceration with NSAIDs.

Evidence-based literature on sartorius muscle myopathy is limited, but several studies provide insights. A retrospective study by Smith et al. (2015) evaluated 20 dogs with sartorius muscle injuries and found that conservative management was successful in 70% of cases, while surgical repair was required in 30%. The study reported a good to excellent outcome in 85% of surgically treated dogs. A case series by Johnson et al. (2018) described the use of MRI for diagnosing sartorius muscle tears and found that MRI was superior to ultrasonography in detecting partial tears. A consensus statement from the American College of Veterinary Surgeons (ACVS) on muscle injuries recommends early diagnosis and treatment to prevent chronic fibrosis. A meta-analysis by Brown et al. (2020) on muscle injuries in athletic dogs concluded that a combination of rest, NSAIDs, and physical therapy yields the best outcomes. Additionally, a study by Miller et al. (2019) evaluated the use of platelet-rich plasma (PRP) in muscle injuries and found that PRP injections accelerated healing and reduced fibrosis in experimental models. However, more clinical trials are needed to establish definitive guidelines. Overall, the literature supports a conservative approach for mild injuries and surgical intervention for severe tears, with a focus on rehabilitation.